The course of headache after the end of treatment with erenumab in patients with episodic and chronic migraine
Background. Migraine is the second most incapacitating disease and is accompanied by multiple comorbidities, especially in chronic migraines. Migraine treatment and improvement of the patients' quality of life are an important clinical issue. The calcitonin gene-related peptide (CGRP) monoclona...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
LLC "MEDIAFORMAT",
2024-05-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|